CNS Pharmaceuticals, Inc. (CNSP)

NASDAQ: CNSP · IEX Real-Time Price · USD

1.260

-0.160 (-11.27%)

At close: Jul 2, 2024, 4:00 PM

1.280

+0.020 (1.59%)

After-hours: Jul 2, 2024, 7:56 PM EDT

CNS Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-18.85	-15.27	-14.5	-9.46	-3.88	Upgrade
Depreciation & Amortization	0	0.01	0.01	0.01	0	Upgrade
Share-Based Compensation	1.01	1.2	1.72	1.29	0.63	Upgrade
Other Operating Activities	3.7	3.5	-0.78	0.84	-0.31	Upgrade
Operating Cash Flow	-14.14	-10.56	-13.54	-7.32	-3.55	Upgrade
Capital Expenditures	-0	-0	-0.01	-0.02	-0.02	Upgrade
Investing Cash Flow	-0	-0	-0.01	-0.02	-0.02	Upgrade
Share Issuance / Repurchase	5.28	16.04	4.99	14.22	10.29	Upgrade
Debt Issued / Paid	-0.44	-0.43	-0.48	-0.04	-0.04	Upgrade
Other Financing Activities	-0.2	-	-	-0.05	-	Upgrade
Financing Cash Flow	4.64	15.61	4.51	14.13	10.26	Upgrade
Net Cash Flow	-9.51	5.05	-9.03	6.8	6.69	Upgrade
Free Cash Flow	-14.14	-10.56	-13.54	-7.34	-3.57	Upgrade
Free Cash Flow Per Share	-187.72	-387.82	-770.91	-662.16	-392.77	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).